Hyperinsulinemia, which can contribute to common defects in insulin/IGF-1 pathways on the pancreatic periphery and in the pancreatic islet β-cell, is considered a key causative factor for the development of DM II [166]. The gene discussed is INS; the disease is Hyperinsulinemia.